Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Thoracic Surgery

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 205 articles:
HTML format
Text format



Single Articles


    June 2018
  1. NG J, Cleary A, Tsukada H, Goldberg H, et al
    A case of recipient-derived pulmonary Kaposi sarcoma after bilateral lung transplantation.
    J Heart Lung Transplant. 2018;37:798-799.
    PubMed     Text format    


    March 2018
  2. DURAND M, Lacoste P, Danger R, Jacquemont L, et al
    High circulating CD4(+)CD25(hi)FOXP3(+) T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndrome.
    J Heart Lung Transplant. 2018 Mar 20. pii: S1053-2498(18)31339.
    PubMed     Text format     Abstract available


  3. FRIED JA, Nair A, Takeda K, Clerkin K, et al
    Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.
    J Heart Lung Transplant. 2018 Mar 20. pii: S1053-2498(18)31396.
    PubMed     Text format     Abstract available


  4. VOS M, Plasmeijer EI, van Bemmel BC, van der Bij W, et al
    Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
    J Heart Lung Transplant. 2018 Mar 19. pii: S1053-2498(18)31397.
    PubMed     Text format     Abstract available


  5. PRADERE P, Tudorache I, Magnusson J, Savale L, et al
    Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study.
    J Heart Lung Transplant. 2018 Mar 15. pii: S1053-2498(18)31388.
    PubMed     Text format     Abstract available


    February 2018
  6. LIU J, Jackson K, Weinkauf J, Kapasi A, et al
    Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation.
    J Heart Lung Transplant. 2018 Feb 27. pii: S1053-2498(18)31380.
    PubMed     Text format     Abstract available


  7. HUSAIN S, Bhaskaran A, Rotstein C, Li Y, et al
    A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal culture.
    J Heart Lung Transplant. 2018 Feb 16. pii: S1053-2498(18)31356.
    PubMed     Text format     Abstract available


  8. CRESPO MM, McCarthy DP, Hopkins PM, Clark SC, et al
    ISHLT Consensus Statement on adult and pediatric airway complications after lung transplantation: Definitions, grading system, and therapeutics.
    J Heart Lung Transplant. 2018 Feb 7. pii: S1053-2498(18)31349.
    PubMed     Text format     Abstract available


    January 2018
  9. BRODA CR, Cabrera AG, Rossano JW, Jefferies JL, et al
    Cardiac transplantation in children with Down syndrome, Turner syndrome, and other chromosomal anomalies: A multi-institutional outcomes analysis.
    J Heart Lung Transplant. 2018 Jan 31. pii: S1053-2498(18)31297.
    PubMed     Text format     Abstract available


  10. SCHLENDORF KH, Zalawadiya S, Shah AS, Wigger M, et al
    Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies.
    J Heart Lung Transplant. 2018 Jan 31. pii: S1053-2498(18)31294.
    PubMed     Text format     Abstract available


    December 2017
  11. HESS ML, Hunt S
    Conquering the first hurdles in cardiac transplantation: In the footprints of giants.
    J Heart Lung Transplant. 2017;36:1276-1278.
    PubMed     Text format    


    November 2017
  12. CAO S, Courtwright AM, Lamattina AM, Guleria I, et al
    The impact of screening method on HLA antibody detection before and after lung transplantation: A prospective pilot study.
    J Heart Lung Transplant. 2017 Nov 22. pii: S1053-2498(17)32119.
    PubMed     Text format    


  13. MITCHELL AB, Glanville AR
    The distal airway microbiome after lung transplantation: A driver of immune regulation?
    J Heart Lung Transplant. 2017 Nov 22. pii: S1053-2498(17)32118.
    PubMed     Text format    


  14. WARE LB
    Targeting resolution of pulmonary edema in primary graft dysfunction after lung transplantation: Is inhaled AP301 the answer?
    J Heart Lung Transplant. 2017 Nov 16. pii: S1053-2498(17)32114.
    PubMed     Text format    


    October 2017
  15. SEE VY
    Organized atrial arrhythmias after cardiac transplantation: The overlooked value of the 12-lead electrocardiogram and cavotricuspid atrial flutter isthmus.
    J Heart Lung Transplant. 2017 Oct 27. pii: S1053-2498(17)32084.
    PubMed     Text format    


  16. SNELL GI, Yusen RD, Weill D, Strueber M, et al
    Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2017;36:1097-1103.
    PubMed     Text format    


    September 2017
  17. AIGNER C, Slama A, Barta M, Mitterbauer A, et al
    Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: A prospective, randomized pilot study.
    J Heart Lung Transplant. 2017 Sep 30. pii: S1053-2498(17)32036.
    PubMed     Text format     Abstract available


    August 2017
  18. GLASS L, Savage A, Haddad O, Kavarana MN, et al
    Continuous-flow, implantable biventricular assist device as bridge to cardiac transplantation in a small child with restrictive cardiomyopathy.
    J Heart Lung Transplant. 2017 Aug 10. pii: S1053-2498(17)31946.
    PubMed     Text format    


    July 2017
  19. DIAMOND JM, Arcasoy S, Kennedy CC, Eberlein M, et al
    Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung
    J Heart Lung Transplant. 2017 Jul 26. pii: S1053-2498(17)31922.
    PubMed     Text format    


  20. GELMAN AE, Fisher AJ, Huang HJ, Baz MA, et al
    Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2017 Jul 24. pii: S1053-2498(17)31905.
    PubMed     Text format    


  21. VAN RAEMDONCK D, Hartwig MG, Hertz MI, Davis RD, et al
    Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2017 Jul 21. pii: S1053-2498(17)31904.
    PubMed     Text format    


  22. SHAH SZ, Pouch SM, Keller BC, Pope-Harman A, et al
    Outcomes from bacteremic donors in lung transplantation.
    J Heart Lung Transplant. 2017 Jul 21. pii: S1053-2498(17)31925.
    PubMed     Text format    


  23. LUND LH, Khush KK, Cherikh WS, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time.
    J Heart Lung Transplant. 2017 Jul 20. pii: S1053-2498(17)31910.
    PubMed     Text format    


  24. ROSSANO JW, Cherikh WS, Chambers DC, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Heart Transplantation Report-2017; Focus Theme: Allograft Ischemic Time.
    J Heart Lung Transplant. 2017 Jul 20. pii: S1053-2498(17)31909.
    PubMed     Text format    


  25. CHAMBERS DC, Yusen RD, Cherikh WS, Goldfarb SB, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.
    J Heart Lung Transplant. 2017 Jul 19. pii: S1053-2498(17)31907.
    PubMed     Text format    


  26. GOLDFARB SB, Levvey BJ, Cherikh WS, Chambers DC, et al
    Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Lung and Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.
    J Heart Lung Transplant. 2017 Jul 19. pii: S1053-2498(17)31908.
    PubMed     Text format    


  27. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Association between antibody functions and human cytomegalovirus (HCMV) replication after lung transplantation in HCMV-seropositive patients.
    J Heart Lung Transplant. 2017 Jul 18. pii: S1053-2498(17)31901.
    PubMed     Text format    


  28. LEUSCHNER G, Stocker F, Veit T, Kneidinger N, et al
    Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy.
    J Heart Lung Transplant. 2017 Jul 5. pii: S1053-2498(17)31886.
    PubMed     Text format     Abstract available


  29. MULVIHILL MS, Yerokun BA, Davis RP, Ranney DN, et al
    Extracorporeal membrane oxygenation following lung transplantation: indications and survival.
    J Heart Lung Transplant. 2017 Jul 1. pii: S1053-2498(17)31880.
    PubMed     Text format     Abstract available


    June 2017
  30. SWEET SC
    Assessing the impact of program volume and composition on waiting list outcomes in pediatric lung transplantation.
    J Heart Lung Transplant. 2017 Jun 21. pii: S1053-2498(17)31871.
    PubMed     Text format    


  31. HASHIMOTO K, Cypel M, Juvet S, Saito T, et al
    Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation.
    J Heart Lung Transplant. 2017 Jun 21. pii: S1053-2498(17)31870.
    PubMed     Text format     Abstract available


    May 2017
  32. VERLEDEN GM, Vos R
    Statins in lung transplantation: A treatment option for every patient?
    J Heart Lung Transplant. 2017 May 25. pii: S1053-2498(17)31810.
    PubMed     Text format    


  33. AGBOR-ENOH S, Tunc I, De Vlaminck I, Fideli U, et al
    Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.
    J Heart Lung Transplant. 2017 May 20. pii: S1053-2498(17)31807.
    PubMed     Text format     Abstract available


  34. ROSTAD CA, Wehrheim K, Kirklin JK, Naftel D, et al
    Bacterial infections after pediatric heart transplantation: Epidemiology, risk factors and outcomes.
    J Heart Lung Transplant. 2017 May 11. pii: S1053-2498(17)31790.
    PubMed     Text format     Abstract available


  35. RAPHAEL J, Collins SR, Wang XQ, Scalzo DC, et al
    Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation.
    J Heart Lung Transplant. 2017 May 6. pii: S1053-2498(17)31783.
    PubMed     Text format     Abstract available


  36. DOBBELS F, De Bleser L, Berben L, Kristanto P, et al
    Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial.
    J Heart Lung Transplant. 2017;36:499-508.
    PubMed     Text format     Abstract available


  37. NAKAJIMA D, Liu M, Ohsumi A, Kalaf R, et al
    Lung Lavage and Surfactant Replacement During Ex Vivo Lung Perfusion for Treatment of Gastric Acid Aspiration-Induced Donor Lung Injury.
    J Heart Lung Transplant. 2017;36:577-585.
    PubMed     Text format     Abstract available


  38. OSHO AA, Castleberry AW, Yerokun BA, Mulvihill MS, et al
    Clinical predictors and outcome implications of early readmission in lung transplant recipients.
    J Heart Lung Transplant. 2017;36:546-553.
    PubMed     Text format     Abstract available


  39. SARMIENTO E, Jaramillo M, Calahorra L, Fernandez-Yanez J, et al
    Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.
    J Heart Lung Transplant. 2017;36:529-539.
    PubMed     Text format     Abstract available


    April 2017
  40. SCULLY BB, Goss M, Liu H, Keuht ML, et al
    Waitlist outcomes in pediatric lung transplantation: Poor results for children listed in adult transplant programs.
    J Heart Lung Transplant. 2017 Apr 24. pii: S1053-2498(17)31753.
    PubMed     Text format     Abstract available


  41. NODA K, Tane S, Haam SJ, Hayanga AJ, et al
    Optimal ex vivo lung perfusion techniques with oxygenated perfusate.
    J Heart Lung Transplant. 2017;36:466-474.
    PubMed     Text format     Abstract available


    March 2017
  42. SEE SB, Clerkin KJ, Kennel PJ, Zhang F, et al
    Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.
    J Heart Lung Transplant. 2017 Mar 24. pii: S1053-2498(17)31733.
    PubMed     Text format     Abstract available


  43. BLATTER JA
    Hard to swallow? Dysmotility, reflux and chronic lung allograft dysfunction in pediatric lung transplantation.
    J Heart Lung Transplant. 2017 Mar 20. pii: S1053-2498(17)31709.
    PubMed     Text format    


  44. VOS R, Ruttens D, Verleden SE, Vandermeulen E, et al
    High-dose vitamin D after lung transplantation: A randomized trial.
    J Heart Lung Transplant. 2017 Mar 8. pii: S1053-2498(17)31685.
    PubMed     Text format     Abstract available


  45. RESCH T, Ashraf MI, Ritschl PV, Ebner S, et al
    Disturbances in iron homeostasis result in accelerated rejection after experimental heart transplantation.
    J Heart Lung Transplant. 2017 Mar 7. pii: S1053-2498(17)31681.
    PubMed     Text format     Abstract available


  46. BULIC A, Maeda K, Zhang Y, Chen S, et al
    Functional status of United States children supported with a left ventricular assist device at heart transplantation.
    J Heart Lung Transplant. 2017 Mar 2. pii: S1053-2498(17)31675.
    PubMed     Text format     Abstract available


  47. LIU Y, Vela M, Rudakevych T, Wigfield C, et al
    Patient factors associated with lung transplant referral and waitlist for patients with cystic fibrosis and pulmonary fibrosis.
    J Heart Lung Transplant. 2017;36:264-271.
    PubMed     Text format     Abstract available


  48. LIU Y, Chen W, Wu C, Minze LJ, et al
    Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.
    J Heart Lung Transplant. 2017;36:340-354.
    PubMed     Text format     Abstract available


    February 2017
  49. COURTWRIGHT A, El-Chemaly S
    Broadening the investigation-short telomeres and lung transplantation outcomes in pulmonary fibrosis.
    J Heart Lung Transplant. 2017 Feb 28. pii: S1053-2498(17)31650.
    PubMed     Text format    


  50. DA COSTA PA, Segatto M, Durso DF, de Carvalho Moreira WJ, et al
    Early polymerase chain reaction detection of Chagas disease reactivation in heart transplant patients.
    J Heart Lung Transplant. 2017 Feb 24. pii: S1053-2498(17)31648.
    PubMed     Text format     Abstract available


  51. SABATINO M, Vitale G, Manfredini V, Masetti M, et al
    Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes.
    J Heart Lung Transplant. 2017 Feb 17. pii: S1053-2498(17)31623.
    PubMed     Text format     Abstract available


  52. PARASKEVA MA, Edwards LB, Levvey B, Stehlik J, et al
    Outcomes of adolescent recipients after lung transplantation: An analysis of the International Society for Heart and Lung Transplantation Registry.
    J Heart Lung Transplant. 2017 Feb 17. pii: S1053-2498(17)31626.
    PubMed     Text format     Abstract available


  53. KRANSDORF EP, Kittleson MM, Patel JK, Pando MJ, et al
    Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list.
    J Heart Lung Transplant. 2017 Feb 17. pii: S1053-2498(17)31624.
    PubMed     Text format     Abstract available


  54. NEWTON CA, Kozlitina J, Lines JR, Kaza V, et al
    Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.
    J Heart Lung Transplant. 2017 Feb 4. pii: S1053-2498(17)31352.
    PubMed     Text format     Abstract available


  55. FERNANDEZ-BUSSY S, Labarca G, Majid A
    In reply: Biodegradable stent for vanishing bronchus syndrome after lung transplantation.
    J Heart Lung Transplant. 2017 Feb 3. pii: S1053-2498(17)31351.
    PubMed     Text format    


  56. BENATTI RD, Oliveira GH, Bacal F
    Heart Transplantation for Chagas Cardiomyopathy.
    J Heart Lung Transplant. 2017 Feb 3. pii: S1053-2498(17)31353.
    PubMed     Text format     Abstract available


  57. BERGENFELDT H, Stehlik J, Hoglund P, Andersson B, et al
    Donor-recipient size matching and mortality in heart transplantation: Influence of body mass index and gender.
    J Heart Lung Transplant. 2017 Feb 3. pii: S1053-2498(17)31349.
    PubMed     Text format     Abstract available


  58. DANDEL M, Hetzer R
    Post-transplant surveillance for acute rejection and allograft vasculopathy by echocardiography: Usefulness of myocardial velocity and deformation imaging.
    J Heart Lung Transplant. 2017;36:117-131.
    PubMed     Text format     Abstract available


  59. WU FM, Earing MG, Aboulhosn JA, Johncilla ME, et al
    Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
    J Heart Lung Transplant. 2017;36:211-219.
    PubMed     Text format     Abstract available


  60. LU C, Zeng YQ, Liu H, Xie Q, et al
    Tanshinol suppresses cardiac allograft rejection in a murine model.
    J Heart Lung Transplant. 2017;36:227-236.
    PubMed     Text format     Abstract available


  61. ZHANG A, Wang K, Zhou C, Gan Z, et al
    Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    J Heart Lung Transplant. 2017;36:175-184.
    PubMed     Text format     Abstract available


    January 2017
  62. CLARKE B, Ducharme A, Giannetti N, Kim D, et al
    Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada.
    J Heart Lung Transplant. 2017 Jan 6. pii: S1053-2498(17)30010.
    PubMed     Text format     Abstract available


  63. GOTTLIEB J, Fuehner T, Greer M
    Biodegradable stent for vanishing bronchus syndrome after lung transplantation.
    J Heart Lung Transplant. 2017 Jan 5. pii: S1053-2498(17)30013.
    PubMed     Text format    


  64. RICH JD, Gosev I, Patel CB, Joseph S, et al
    The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device.
    J Heart Lung Transplant. 2017;36:50-58.
    PubMed     Text format     Abstract available


  65. DOBARRO D, Urban M, Booth K, Wrightson N, et al
    Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    J Heart Lung Transplant. 2017;36:42-49.
    PubMed     Text format     Abstract available


    December 2016
  66. COURTWRIGHT AM, El-Chemaly S, Dellaripa PF, Goldberg HJ, et al
    Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease.
    J Heart Lung Transplant. 2016 Dec 31. pii: S1053-2498(16)30492.
    PubMed     Text format     Abstract available


  67. DARDAS TF, Kim M, Bansal A, Heagerty P, et al
    Agreement between risk and priority for heart transplant: Effects of the geographic allocation rule and status assignment.
    J Heart Lung Transplant. 2016 Dec 23. pii: S1053-2498(16)30469.
    PubMed     Text format     Abstract available


  68. TAKEDA K, Li B, Garan AR, Topkara VK, et al
    Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    J Heart Lung Transplant. 2016 Dec 23. pii: S1053-2498(16)30466.
    PubMed     Text format     Abstract available


  69. GODA Y, Motoyama H, Aoyama A, Hamaji M, et al
    Right-to-left inverted living-donor lobar lung transplantation combined with sparing of native right upper lobe.
    J Heart Lung Transplant. 2016 Dec 20. pii: S1053-2498(16)30444.
    PubMed     Text format    


  70. CLEMMENSEN TS, Eiskjaer H, Logstrup BB, Ilkjaer LB, et al
    Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
    J Heart Lung Transplant. 2016 Dec 15. pii: S1053-2498(16)30443.
    PubMed     Text format     Abstract available


  71. RAJAGOPAL K, Hoeper MM
    State of the Art: Bridging to lung transplantation using artificial organ support technologies.
    J Heart Lung Transplant. 2016;35:1385-1398.
    PubMed     Text format     Abstract available


  72. WESTBROOK TC, Morales DL, Khan MS, Bryant R, et al
    Interaction of older donor age and survival after weight-matched pediatric heart transplantation.
    J Heart Lung Transplant. 2016 Dec 1. pii: S1053-2498(16)30438.
    PubMed     Text format     Abstract available


  73. CHINALI M, Esposito C, Grutter G, Iacobelli R, et al
    Cardiac dysfunction in children and young adults with heart transplantation: A comprehensive echocardiography study.
    J Heart Lung Transplant. 2016 Dec 1. pii: S1053-2498(16)30436.
    PubMed     Text format     Abstract available


    November 2016
  74. CLERKIN KJ, Farr MA, Restaino SW, Zorn E, et al
    Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    J Heart Lung Transplant. 2016 Nov 17. pii: S1053-2498(16)30403.
    PubMed     Text format     Abstract available


  75. FERNANDEZ-BUSSY S, Labarca G, Majid A
    Biodegradable stent for vanishing bronchus syndrome after lung transplantation.
    J Heart Lung Transplant. 2016;35:1378-1379.
    PubMed     Text format    


    October 2016
  76. GORZER I, Jaksch P, Strassl R, Klepetko W, et al
    Association between plasma Torque teno virus level and chronic lung allograft dysfunction after lung transplantation.
    J Heart Lung Transplant. 2016 Oct 21. pii: S1053-2498(16)30386.
    PubMed     Text format    


  77. LANCASTER TS, Miller JR, Epstein DJ, DuPont NC, et al
    Improved waitlist and transplant outcomes for pediatric lung transplantation after implementation of the lung allocation score.
    J Heart Lung Transplant. 2016 Oct 17. pii: S1053-2498(16)30365.
    PubMed     Text format     Abstract available


  78. ZALAWADIYA S, Fudim M, Bhat G, Cotts W, et al
    Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults.
    J Heart Lung Transplant. 2016 Oct 15. pii: S1053-2498(16)30366.
    PubMed     Text format     Abstract available


  79. MCILVENNAN CK
    Looking on the BRIGHT side of health literacy in patients with cardiac transplantation: Where are we and where do we need to go?
    J Heart Lung Transplant. 2016 Oct 13. pii: S1053-2498(16)30347.
    PubMed     Text format    


  80. MOLLBERG NM, Howell E, Vanderhoff DI, Cheng A, et al
    Health care utilization and consequences of readmission in the first year after lung transplantation.
    J Heart Lung Transplant. 2016 Oct 7. pii: S1053-2498(16)30343.
    PubMed     Text format     Abstract available


  81. ZINN MD, Wallendorf MJ, Simpson KE, Osborne AD, et al
    Impact of age on incidence and prevalence of moderate-to-severe cellular rejection detected by routine surveillance biopsy in pediatric heart transplantation.
    J Heart Lung Transplant. 2016 Oct 7. pii: S1053-2498(16)30346.
    PubMed     Text format     Abstract available


  82. ROSSANO JW, Jefferies JL, Pahl E, Naftel DC, et al
    Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group.
    J Heart Lung Transplant. 2016 Oct 4. pii: S1053-2498(16)30337.
    PubMed     Text format     Abstract available


  83. DALY KP, Stack M, Eisenga MF, Keane JF, et al
    Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    J Heart Lung Transplant. 2016 Oct 3. pii: S1053-2498(16)30341.
    PubMed     Text format     Abstract available


  84. GOLDFARB SB, Levvey BJ, Edwards LB, Dipchand AI, et al
    The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Lung and Heart-Lung Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1196-1205.
    PubMed     Text format    


  85. ROSSANO JW, Dipchand AI, Edwards LB, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1185-1195.
    PubMed     Text format    


  86. YUSEN RD, Edwards LB, Dipchand AI, Goldfarb SB, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1170-1184.
    PubMed     Text format    


  87. LUND LH, Edwards LB, Dipchand AI, Goldfarb S, et al
    The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
    J Heart Lung Transplant. 2016;35:1158-1169.
    PubMed     Text format    


  88. DAVIES RR, McCulloch MA, Haldeman S, Gidding SS, et al
    Urgent listing exceptions and outcomes in pediatric heart transplantation: Comparison to standard criteria patients.
    J Heart Lung Transplant. 2016 Oct 1. pii: S1053-2498(16)30335.
    PubMed     Text format     Abstract available


    September 2016
  89. SIVATHASAN C, Lim CP, Kerk KL, Sim DK, et al
    Mechanical circulatory support and heart transplantation in the Asia Pacific region.
    J Heart Lung Transplant. 2016 Sep 29. pii: S1053-2498(16)30334.
    PubMed     Text format     Abstract available


  90. GOLDBERG HJ
    Maintaining airway integrity after lung transplantation-Could an ounce of prevention be worth a pound of cure?
    J Heart Lung Transplant. 2016 Sep 13. pii: S1053-2498(16)30317.
    PubMed     Text format    


  91. KOVARIK JJ, Kopecky C, Antlanger M, Domenig O, et al
    Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.
    J Heart Lung Transplant. 2016 Sep 13. pii: S1053-2498(16)30310.
    PubMed     Text format     Abstract available


  92. CAJITA MI, Denhaerynck K, Dobbels F, Berben L, et al
    Health literacy in heart transplantation: Prevalence, correlates and associations with health behaviors-Findings from the international BRIGHT study.
    J Heart Lung Transplant. 2016 Sep 13. pii: S1053-2498(16)30312.
    PubMed     Text format     Abstract available


  93. XU Z, Sharma M, Gelman A, Hachem R, et al
    Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation.
    J Heart Lung Transplant. 2016 Sep 12. pii: S1053-2498(16)30316.
    PubMed     Text format     Abstract available


  94. HAYES D JR, Reynolds SD, Tumin D
    Outcomes of lung transplantation for primary ciliary dyskinesia and Kartagener syndrome.
    J Heart Lung Transplant. 2016 Sep 7. pii: S1053-2498(16)30313.
    PubMed     Text format    


    August 2016
  95. FORCONI C, Gatault P, Miquelestorena-Standley E, Noble J, et al
    Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    J Heart Lung Transplant. 2016 Aug 26. pii: S1053-2498(16)30295.
    PubMed     Text format     Abstract available


  96. WEVER-PINZON O, Edwards LB, Taylor DO, Kfoury AG, et al
    Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    J Heart Lung Transplant. 2016 Aug 20. pii: S1053-2498(16)30289.
    PubMed     Text format     Abstract available


  97. LEARD LE
    Lung transplantation after prior cardiothoracic surgery: To transplant or not to transplant.
    J Heart Lung Transplant. 2016 Aug 20. pii: S1053-2498(16)30288.
    PubMed     Text format    


  98. CHAN JL, Kobashigawa JA, Reich HJ, Ramzy D, et al
    Intermediate outcomes with ex-vivo allograft perfusion for heart transplantation.
    J Heart Lung Transplant. 2016 Aug 20. pii: S1053-2498(16)30296.
    PubMed     Text format     Abstract available


  99. GRUPPER A, Grupper A, Daly RC, Pereira NL, et al
    Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation.
    J Heart Lung Transplant. 2016 Aug 18. pii: S1053-2498(16)30285.
    PubMed     Text format     Abstract available


  100. OLLAND A, Reeb J, Puyraveau M, Hirschi S, et al
    Bronchial complications after lung transplantation are associated with primary lung graft dysfunction and surgical technique.
    J Heart Lung Transplant. 2016 Aug 17. pii: S1053-2498(16)30284.
    PubMed     Text format     Abstract available


  101. BANGA A, Mohanka M, Mullins J, Bollineni S, et al
    Hospital length of stay after lung transplantation: Independent predictors and association with early and late survival.
    J Heart Lung Transplant. 2016 Aug 11. pii: S1053-2498(16)30281.
    PubMed     Text format     Abstract available


    July 2016
  102. COOPER LB, Mentz RJ, Edwards LB, Wilk AR, et al
    Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.
    J Heart Lung Transplant. 2016 Jul 17. pii: S1053-2498(16)30249.
    PubMed     Text format     Abstract available


  103. JAVAHERI A, Molina M, Zamani P, Rodrigues A, et al
    Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients.
    J Heart Lung Transplant. 2016 Jul 15. pii: S1053-2498(16)30216.
    PubMed     Text format     Abstract available


  104. DIAZ-GUZMAN E, Sharma NS, Wille K, Hoopes CW, et al
    Use of a novel pulmonary artery cannula to provide extracorporeal membrane oxygenation as a bridge to lung transplantation.
    J Heart Lung Transplant. 2016 Jul 1. pii: S1053-2498(16)30141.
    PubMed     Text format    


    June 2016
  105. RAGHAVAN D, Gao A, Ahn C, Kaza V, et al
    Lung transplantation and gender effects on survival of recipients with cystic fibrosis.
    J Heart Lung Transplant. 2016 Jun 24. pii: S1053-2498(16)30191.
    PubMed     Text format     Abstract available


  106. MCDIARMID AK, Plein S, Ross HJ
    Emerging imaging techniques after cardiac transplantation.
    J Heart Lung Transplant. 2016 Jun 24. pii: S1053-2498(16)30195.
    PubMed     Text format     Abstract available


  107. FORAKER RE, Tumin D, Smith S, Tobias JD, et al
    Insurance status by region at the time of heart transplantation: Implications for survival.
    J Heart Lung Transplant. 2016 Jun 24. pii: S1053-2498(16)30190.
    PubMed     Text format     Abstract available


  108. THRUSH PT, Pahl E, Naftel DC, Pruitt E, et al
    A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes.
    J Heart Lung Transplant. 2016 Jun 24. pii: S1053-2498(16)30192.
    PubMed     Text format     Abstract available


  109. MCKELLAR SH, Bowen ME, Baird BC, Raman S, et al
    Lung transplantation following coronary artery bypass surgery-improved outcomes following single-lung transplant.
    J Heart Lung Transplant. 2016 Jun 14. pii: S1053-2498(16)30174.
    PubMed     Text format     Abstract available


  110. OMARA M, Okamoto T, Arafat A, Thuita L, et al
    Lung transplantation in patients who have undergone prior cardiothoracic procedures.
    J Heart Lung Transplant. 2016 Jun 14. pii: S1053-2498(16)30175.
    PubMed     Text format     Abstract available


  111. VOGL M, Warnecke G, Haverich A, Gottlieb J, et al
    Lung transplantation in the spotlight: Reasons for high-cost procedures.
    J Heart Lung Transplant. 2016 Jun 7. pii: S1053-2498(16)30165.
    PubMed     Text format     Abstract available


  112. KIMURA N, Khan MS, Schecter M, Rizwan R, et al
    Changing demographics and outcomes of lung transplantation recipients with cystic fibrosis.
    J Heart Lung Transplant. 2016 Jun 7. pii: S1053-2498(16)30166.
    PubMed     Text format     Abstract available


  113. PARK KH, Sun T, Liu Z, Yang SW, et al
    Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    J Heart Lung Transplant. 2016 Jun 7. pii: S1053-2498(16)30169.
    PubMed     Text format     Abstract available


  114. DOUMOURAS BS, Alba AC, Foroutan F, Burchill LJ, et al
    Outcomes in adult congenital heart disease patients undergoing heart transplantation: A systematic review and meta-analysis.
    J Heart Lung Transplant. 2016 Jun 7. pii: S1053-2498(16)30167.
    PubMed     Text format     Abstract available


  115. HABIB PJ, Patel PC, Hodge D, Chimato N, et al
    Pre-orthotopic heart transplant estimated glomerular filtration rate predicts post-transplant mortality and renal outcomes: An analysis of the UNOS database.
    J Heart Lung Transplant. 2016 Jun 7. pii: S1053-2498(16)30173.
    PubMed     Text format     Abstract available


    May 2016
  116. LE PAVEC J, Suberbielle C, Lamrani L, Feuillet S, et al
    De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome.
    J Heart Lung Transplant. 2016 May 31. pii: S1053-2498(16)30145.
    PubMed     Text format     Abstract available


  117. HAYES D, Joy BF, Reynolds SD, Tobias JD, et al
    Influence of graft ischemic time and geographic distance between donor and recipient on survival in children after lung transplantation.
    J Heart Lung Transplant. 2016 May 27. pii: S1053-2498(16)30143.
    PubMed     Text format     Abstract available


  118. WALSH JR, Chambers DC, Yerkovich ST, Hopkins PM, et al
    Low levels of physical activity predict worse survival to lung transplantation and poor early post-operative outcomes.
    J Heart Lung Transplant. 2016 May 20. pii: S1053-2498(16)30138.
    PubMed     Text format    


  119. NAU M, Shrider EA, Tobias JD, Hayes D Jr, et al
    High local unemployment rates limit work after lung transplantation.
    J Heart Lung Transplant. 2016 May 16. pii: S1053-2498(16)30127.
    PubMed     Text format     Abstract available


  120. EBERLEIN M
    Excessive dynamic airway collapse and lung transplantation.
    J Heart Lung Transplant. 2016 May 16. pii: S1053-2498(16)30128.
    PubMed     Text format    


  121. FREEMAN N, Le LW, Singer LG, Colman R, et al
    Impact of a transplant palliative care clinic on symptoms for patients awaiting lung transplantation.
    J Heart Lung Transplant. 2016 May 16. pii: S1053-2498(16)30131.
    PubMed     Text format    


  122. VARR BC, Restaino SW, Farr M, Scully B, et al
    Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy.
    J Heart Lung Transplant. 2016 May 11. pii: S1053-2498(16)30120.
    PubMed     Text format     Abstract available


  123. TOMASKO J, Prasad SM, Dell DO, DeCamp MM, et al
    Therapeutic anticoagulation-free extracorporeal membrane oxygenation as a bridge to lung transplantation.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30108.
    PubMed     Text format    


  124. HAYES D JR, Glanville AR, McGiffin D, Tobias JD, et al
    Age-related survival disparity associated with lung transplantation in cystic fibrosis: An analysis of the registry of the International Society for Heart and Lung Transplantation.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30119.
    PubMed     Text format     Abstract available


  125. VAN BESOUW NM, van Hal PT, Zuijderwijk JM, de Kuiper R, et al
    Herpes zoster after lung transplantation boosts varicella zoster virus-specific adaptive immune responses.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30113.
    PubMed     Text format     Abstract available


  126. AWORI HAYANGA JW, Aboagye JK, Shigemura N, Hayanga HK, et al
    Airway complications after lung transplantation: Contemporary survival and outcomes.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30123.
    PubMed     Text format     Abstract available


  127. KO BS, Drakos S, Kfoury AG, Hurst D, et al
    Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30111.
    PubMed     Text format     Abstract available


  128. JHA SR, Hannu MK, Gore K, Chang S, et al
    Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation.
    J Heart Lung Transplant. 2016 May 6. pii: S1053-2498(16)30112.
    PubMed     Text format     Abstract available


    April 2016
  129. VERLEDEN SE, Ruttens D, Vandermeulen E, Bellon H, et al
    Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.
    J Heart Lung Transplant. 2016 Apr 16. pii: S1053-2498(16)30096.
    PubMed     Text format     Abstract available


  130. XU Z, Ramachandran S, Gunasekaran M, Zhou F, et al
    MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome.
    J Heart Lung Transplant. 2016;35:543-4.
    PubMed     Text format    


  131. HALUSHKA MK
    MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome.
    J Heart Lung Transplant. 2016;35:543.
    PubMed     Text format    


  132. SCHREPFER S, Cantu E, Gandy K, Baan CC, et al
    "Bioengineered lungs" Best science paper in JHLT 2014-2015.
    J Heart Lung Transplant. 2016;35:544-6.
    PubMed     Text format    


  133. SEIDELMANN SB, Laur O, Hwa J, Depasquale E, et al
    Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing.
    J Heart Lung Transplant. 2016;35:474-80.
    PubMed     Text format     Abstract available


  134. SHEHAB S, Macdonald PS, Keogh AM, Kotlyar E, et al
    Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.
    J Heart Lung Transplant. 2016;35:466-73.
    PubMed     Text format     Abstract available


  135. OISHI H, Martinu T, Sato M, Matsuda Y, et al
    Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.
    J Heart Lung Transplant. 2016;35:518-27.
    PubMed     Text format     Abstract available


  136. YAMADA Y, Jang JH, De Meester I, Baerts L, et al
    CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
    J Heart Lung Transplant. 2016;35:508-17.
    PubMed     Text format     Abstract available


    March 2016
  137. CHIH S, Patel J
    Desensitization strategies in adult heart transplantation-Will persistence pay off?
    J Heart Lung Transplant. 2016 Mar 31. pii: S1053-2498(16)30074.
    PubMed     Text format     Abstract available


  138. CHENG R, Azarbal B, Yung A, Patel JK, et al
    Elevated immune monitoring as measured by increased adenosine triphosphate production in activated lymphocytes is associated with accelerated development of cardiac allograft vasculopathy after cardiac transplantation.
    J Heart Lung Transplant. 2016 Mar 31. pii: S1053-2498(16)30069.
    PubMed     Text format     Abstract available


  139. NGUYEN VP, Givens RC, Cheng RK, Mokadam NA, et al
    Effect of regional competition on heart transplant waiting list outcomes.
    J Heart Lung Transplant. 2016 Mar 30. pii: S1053-2498(16)30070.
    PubMed     Text format     Abstract available


  140. SOLBERG OG, Stavem K, Ragnarsson A, Ioanes D, et al
    Index of Microvascular Resistance after early conversion from calcineurin inhibitor to everolimus in heart transplantation: A sub-study to a 1-year randomized trial.
    J Heart Lung Transplant. 2016 Mar 17. pii: S1053-2498(16)30049.
    PubMed     Text format     Abstract available


  141. WEVER-PINZON O, Naka Y, Garan AR, Takeda K, et al
    National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.
    J Heart Lung Transplant. 2016 Mar 11. pii: S1053-2498(16)30043.
    PubMed     Text format     Abstract available


  142. HONG KN, Merlo A, Chauhan D, Davies RR, et al
    Evidence supports severe renal insufficiency as a relative contraindication to heart transplantation.
    J Heart Lung Transplant. 2016 Mar 11. pii: S1053-2498(16)30042.
    PubMed     Text format     Abstract available


  143. KITAHARA H, Okada K, Tanaka S, Yang HM, et al
    Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.
    J Heart Lung Transplant. 2016 Mar 10. pii: S1053-2498(16)30041.
    PubMed     Text format     Abstract available


  144. MILLER JR, Simpson KE, Epstein DJ, Lancaster TS, et al
    Improved survival after heart transplant for failed Fontan patients with preserved ventricular function.
    J Heart Lung Transplant. 2016 Mar 10. pii: S1053-2498(16)30044.
    PubMed     Text format     Abstract available


  145. DALY KP
    Finding the correct role for heart transplant in the treatment of hypoplastic left heart syndrome.
    J Heart Lung Transplant. 2016;35:299-300.
    PubMed     Text format    


  146. HAMMOND ME, Revelo MP, Miller DV, Snow GL, et al
    ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
    J Heart Lung Transplant. 2016;35:320-5.
    PubMed     Text format     Abstract available


  147. PECHA S, Eschenhagen T, Reichenspurner H
    Myocardial tissue engineering for cardiac repair.
    J Heart Lung Transplant. 2016;35:294-8.
    PubMed     Text format     Abstract available


  148. SUN Y, Jin X, Liu X, Zhang M, et al
    MicroRNA let-7i regulates dendritic cells maturation targeting interleukin-10 via the Janus kinase 1-signal transducer and activator of transcription 3 signal pathway subsequently induces prolonged cardiac allograft survival in rats.
    J Heart Lung Transplant. 2016;35:378-88.
    PubMed     Text format     Abstract available


    February 2016
  149. MORRIS AA, Kransdorf EP, Coleman BL, Colvin M, et al
    Racial and ethnic disparities in outcomes after heart transplantation: A systematic review of contributing factors and future directions to close the outcomes gap.
    J Heart Lung Transplant. 2016 Feb 12. pii: S1053-2498(16)01285.
    PubMed     Text format     Abstract available


  150. THOMAS MORGAN C, Manlhiot C, McCrindle BW, Dipchand AI, et al
    Outcome, incidence and risk factors for stroke after pediatric heart transplantation: An analysis of the International Society for Heart and Lung Transplantation registry.
    J Heart Lung Transplant. 2016 Feb 9. pii: S1053-2498(16)01280.
    PubMed     Text format     Abstract available


  151. REINSMOEN NL, Patel J, Mirocha J, Lai CH, et al
    Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.
    J Heart Lung Transplant. 2016;35:165-72.
    PubMed     Text format     Abstract available


  152. TAGHAVI S, Jayarajan SN, Komaroff E, Mangi AA, et al
    Right ventricular assist device results in worse post-transplant survival.
    J Heart Lung Transplant. 2016;35:236-41.
    PubMed     Text format     Abstract available


  153. ZALAWADIYA SK, Wigger M, DiSalvo T, Haglund N, et al
    Mechanical circulatory support and simultaneous heart-kidney transplantation: An outcome analysis.
    J Heart Lung Transplant. 2016;35:203-12.
    PubMed     Text format     Abstract available


  154. HAYES D JR, Black SM, Tobias JD, Kopp BT, et al
    Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation.
    J Heart Lung Transplant. 2016;35:186-94.
    PubMed     Text format     Abstract available


  155. GOTTLIEB J, Zamora MR, Hodges T, Musk AW, et al
    ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.
    J Heart Lung Transplant. 2016;35:213-21.
    PubMed     Text format     Abstract available


  156. SEILER A, Klaghofer R, Ture M, Komossa K, et al
    A systematic review of health-related quality of life and psychological outcomes after lung transplantation.
    J Heart Lung Transplant. 2016;35:195-202.
    PubMed     Text format     Abstract available


    January 2016
  157. CHIU P, Schaffer JM, Oyer PE, Pham M, et al
    Influence of durable mechanical circulatory support and allosensitization on mortality after heart transplantation.
    J Heart Lung Transplant. 2016 Jan 7. pii: S1053-2498(16)00018.
    PubMed     Text format     Abstract available


  158. LAL AK, Pruitt E, Hong BJ, Lin KY, et al
    Left ventricular non-compaction cardiomyopathy in children listed for heart transplant: Analysis from the Pediatric Heart Transplant Study Group.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00005.
    PubMed     Text format    


  159. URSCHEL S, Ryan LA, M Larsen I, Biffis K, et al
    Development of B-cell memory in early childhood and the impact on antigen-specific tolerance after heart transplantation.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00004.
    PubMed     Text format     Abstract available


  160. CUENCA S, Ruiz-Cano MJ, Gimeno-Blanes JR, Jurado A, et al
    Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00009.
    PubMed     Text format     Abstract available


  161. KRISHNAMURTHY Y, Cooper LB, Lu D, Schroder JN, et al
    Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00012.
    PubMed     Text format     Abstract available


  162. WALLACE WD, Li N, Andersen CB, Arrossi AV, et al
    Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies.
    J Heart Lung Transplant. 2016;35:40-8.
    PubMed     Text format     Abstract available


  163. DARLEY DR, Malouf MA, Glanville AR
    A rare case of everolimus-induced pulmonary alveolar proteinosis.
    J Heart Lung Transplant. 2016;35:147-8.
    PubMed     Text format    


  164. GUZMAN-PRUNEDA FA, Orr Y, Trost JG, Zhang W, et al
    Bronchial artery revascularization and en bloc lung transplant in children.
    J Heart Lung Transplant. 2016;35:122-9.
    PubMed     Text format     Abstract available


  165. NOGUCHI R, Nakayama K, Itoh M, Kamohara K, et al
    Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease.
    J Heart Lung Transplant. 2016;35:137-45.
    PubMed     Text format     Abstract available


  166. SAITO T, Horie M, Sato M, Nakajima D, et al
    Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    J Heart Lung Transplant. 2016;35:59-66.
    PubMed     Text format     Abstract available


  167. HSIN MK, Iskender I, Nakajima D, Chen M, et al
    Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion.
    J Heart Lung Transplant. 2016;35:130-6.
    PubMed     Text format     Abstract available


  168. ROSS HJ
    The ethics of risk and innovation.
    J Heart Lung Transplant. 2016;35:24-5.
    PubMed     Text format    


  169. IUS F, Sommer W, Tudorache I, Avsar M, et al
    Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results.
    J Heart Lung Transplant. 2016;35:49-58.
    PubMed     Text format     Abstract available


  170. CHAIKRIANGKRAI K, Jyothula S, Jhun HY, Estep J, et al
    Impact of pre-operative coronary artery disease on cardiovascular events following lung transplantation.
    J Heart Lung Transplant. 2016;35:115-21.
    PubMed     Text format     Abstract available


    November 2015
  171. GREENWAY SC, Butts R, Naftel DC, Pruitt E, et al
    Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents.
    J Heart Lung Transplant. 2015 Nov 22. pii: S1053-2498(15)01517.
    PubMed     Text format     Abstract available


  172. SIMON B, Weseslindtner L, Gorzer I, Pollak K, et al
    Subclass-specific antibody responses to human cytomegalovirus in lung transplant recipients and their association with constant heavy immunoglobulin G chain polymorphism and virus replication.
    J Heart Lung Transplant. 2015 Nov 5. pii: S1053-2498(15)01487.
    PubMed     Text format     Abstract available


    October 2015
  173. CASTLEBERRY CD, Zafar F, Dipchand AI, Edwards L, et al
    Early initiation of mTOR inhibitors in children with heart transplantation: A propensity-based registry analysis.
    J Heart Lung Transplant. 2015 Oct 30. pii: S1053-2498(15)01486.
    PubMed     Text format    


  174. CARLO WF, West SC, McCulloch M, Naftel DC, et al
    Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study.
    J Heart Lung Transplant. 2015 Oct 30. pii: S1053-2498(15)01493.
    PubMed     Text format     Abstract available


  175. KULKARNI A, Neugebauer R, Lo Y, Gao Q, et al
    Outcomes and risk factors for listing for heart transplantation after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial.
    J Heart Lung Transplant. 2015 Oct 30. pii: S1053-2498(15)01494.
    PubMed     Text format     Abstract available


  176. KFOURY AG, Miller DV, Snow GL, Afshar K, et al
    Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations.
    J Heart Lung Transplant. 2015 Oct 23. pii: S1053-2498(15)01477.
    PubMed     Text format     Abstract available


  177. GREENWAY SC, Crossland DS, Hudson M, Martin SR, et al
    Fontan-associated liver disease: Implications for heart transplantation.
    J Heart Lung Transplant. 2015 Oct 19. pii: S1053-2498(15)01476.
    PubMed     Text format     Abstract available


  178. DEO SV, Al-Kindi SG, Altarabsheh SE, Hang D, et al
    Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the united network for organ sharing.
    J Heart Lung Transplant. 2015 Oct 9. pii: S1053-2498(15)01455.
    PubMed     Text format     Abstract available


  179. WARE AL, Malmberg E, Delgado JC, Hammond ME, et al
    The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children.
    J Heart Lung Transplant. 2015 Oct 8. pii: S1053-2498(15)01453.
    PubMed     Text format     Abstract available


  180. EVANS JD, Pettit SJ, Goddard M, Lewis C, et al
    Alemtuzumab as a novel treatment for refractory giant cell myocarditis after heart transplantation.
    J Heart Lung Transplant. 2015 Oct 8. pii: S1053-2498(15)01456.
    PubMed     Text format    


  181. COLVIN M, Miranda-Herrera D, Gustafson SK, Heubner B, et al
    Impact of increased time at the highest urgency category on heart transplant outcomes for candidates with ventricular assist devices.
    J Heart Lung Transplant. 2015 Oct 8. pii: S1053-2498(15)01458.
    PubMed     Text format     Abstract available


    September 2015
  182. TOMAI F, De Luca L, Petrolini A, Di Vito L, et al
    Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    J Heart Lung Transplant. 2015 Sep 3. pii: S1053-2498(15)01386.
    PubMed     Text format     Abstract available


  183. TRAN A, Fixler D, Huang R, Meza T, et al
    Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
    J Heart Lung Transplant. 2015 Sep 3. pii: S1053-2498(15)01383.
    PubMed     Text format     Abstract available


  184. AL-KINDI SG, El-Assaad I, Abi Khalil C, Oliveira GH, et al
    Heart transplantation of Middle Eastern patients in the United States: A brief report from the UNOS database.
    J Heart Lung Transplant. 2015;34:1219-20.
    PubMed     Text format    


    July 2015
  185. HOUSTON BA, Kalathiya RJ, Stevens GR, Russell SD, et al
    One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension?
    J Heart Lung Transplant. 2015 Jul 29. pii: S1053-2498(15)01366.
    PubMed     Text format    


  186. HEALY AH, Stehlik J, Edwards LB, McKellar SH, et al
    Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices-an analysis of the international society for heart and lung transplantation transplant registry.
    J Heart Lung Transplant. 2015 Jul 29. pii: S1053-2498(15)01369.
    PubMed     Text format     Abstract available


  187. HEGEDUS P, Li S, Korkmaz-Icoz S, Radovits T, et al
    Dimethyloxalylglycine treatment of brain-dead donor rats improves both donor and graft left ventricular function after heart transplantation.
    J Heart Lung Transplant. 2015 Jul 4. pii: S1053-2498(15)01338.
    PubMed     Text format     Abstract available


    June 2015
  188. MONTANARI S, Dayan V, Yannarelli G, Billia F, et al
    Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model.
    J Heart Lung Transplant. 2015 Jun 12. pii: S1053-2498(15)01279.
    PubMed     Text format     Abstract available


  189. LOGANATHAN S, Korkmaz-Icoz S, Radovits T, Li S, et al
    Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
    J Heart Lung Transplant. 2015 Jun 11. pii: S1053-2498(15)01277.
    PubMed     Text format     Abstract available


  190. DARE AJ, Logan A, Prime TA, Rogatti S, et al
    The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model.
    J Heart Lung Transplant. 2015 Jun 11. pii: S1053-2498(15)01278.
    PubMed     Text format     Abstract available


  191. GRIMM JC, Kilic A, Shah AS, Trent Magruder J, et al
    The influence of institutional volume on the incidence of complications and their effect on mortality after heart transplantation.
    J Heart Lung Transplant. 2015 Jun 10. pii: S1053-2498(15)01286.
    PubMed     Text format     Abstract available


  192. DAVIES RR, Haldeman S, McCulloch MA, Gidding SS, et al
    Low body mass index is associated with increased waitlist mortality among children listed for heart transplant.
    J Heart Lung Transplant. 2015 Jun 10. pii: S1053-2498(15)01297.
    PubMed     Text format     Abstract available


    May 2015
  193. ANSARI D, Lund LH, Stehlik J, Andersson B, et al
    Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
    J Heart Lung Transplant. 2015 May 2. pii: S1053-2498(15)01204.
    PubMed     Text format     Abstract available


    April 2015
  194. HERNANDEZ LE, Shepard CW, Menk J, Lilliam VC, et al
    Global left ventricular relaxation: A novel tissue Doppler index of acute rejection in pediatric heart transplantation.
    J Heart Lung Transplant. 2015 Apr 11. pii: S1053-2498(15)01185.
    PubMed     Text format     Abstract available


  195. LAKDAWALA NK
    Big data for a rare disease: Examining heart transplantation for left ventricular noncompaction in the United Network of Organ Sharing registry.
    J Heart Lung Transplant. 2015 Apr 4. pii: S1053-2498(15)01115.
    PubMed     Text format    


    March 2015
  196. SCHUMACHER KR, Gossett J, Guleserian K, Naftel DC, et al
    Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis.
    J Heart Lung Transplant. 2015 Mar 30. pii: S1053-2498(15)01149.
    PubMed     Text format     Abstract available


  197. DELGADO JF, Reyne AG, de Dios S, Lopez-Medrano F, et al
    Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
    J Heart Lung Transplant. 2015 Mar 26. pii: S1053-2498(15)01111.
    PubMed     Text format     Abstract available


  198. COUTANCE G, Ouldamar S, Rouvier P, Saheb S, et al
    Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.
    J Heart Lung Transplant. 2015 Mar 20. pii: S1053-2498(15)01098.
    PubMed     Text format     Abstract available


    February 2015
  199. DALL CH, Gustafsson F, Christensen SB, Dela F, et al
    Effect of moderate- versus high-intensity exercise on vascular function, biomarkers and quality of life in heart transplant recipients: A randomized, crossover trial.
    J Heart Lung Transplant. 2015 Feb 7. pii: S1053-2498(15)01041.
    PubMed     Text format     Abstract available


  200. KHUU T, Cadeiras M, Wisniewski N, Reed EF, et al
    Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation.
    J Heart Lung Transplant. 2015 Feb 7. pii: S1053-2498(15)01030.
    PubMed     Text format    


  201. POTENA L, Masetti M, Sabatino M, Bacchi-Reggiani ML, et al
    Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation.
    J Heart Lung Transplant. 2015 Feb 7. pii: S1053-2498(15)01038.
    PubMed     Text format     Abstract available


    December 2014
  202. MORRIS AA, Kalogeropoulos AP, Zhao L, Owen M, et al
    Race and ethnic differences in the epidemiology and risk factors for graft failure after heart transplantation.
    J Heart Lung Transplant. 2014 Dec 24. pii: S1053-2498(14)01507.
    PubMed     Text format     Abstract available


    November 2014
  203. JEEWA A, Chin C, Pahl E, Atz AM, et al
    Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study.
    J Heart Lung Transplant. 2014 Nov 15. pii: S1053-2498(14)01444.
    PubMed     Text format     Abstract available


  204. AL-KINDI SG, El-Amm C, Ginwalla M, Hoit BD, et al
    Heart transplant outcomes in patients with left ventricular non-compaction cardiomyopathy.
    J Heart Lung Transplant. 2014 Nov 8. pii: S1053-2498(14)01438.
    PubMed     Text format     Abstract available


  205. ROIG E, Almenar L, Crespo-Leiro M, Segovia J, et al
    Heart transplantation using allografts from older donors: Multicenter study results.
    J Heart Lung Transplant. 2014 Nov 4. pii: S1053-2498(14)01427.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: